1. Home
  2. WGSWW vs EIIA Comparison

WGSWW vs EIIA Comparison

Compare WGSWW & EIIA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • WGSWW
  • EIIA
  • Stock Information
  • Founded
  • WGSWW 2017
  • EIIA N/A
  • Country
  • WGSWW United States
  • EIIA
  • Employees
  • WGSWW 1000
  • EIIA N/A
  • Industry
  • WGSWW Retail: Computer Software & Peripheral Equipment
  • EIIA
  • Sector
  • WGSWW Technology
  • EIIA
  • Exchange
  • WGSWW Nasdaq
  • EIIA Nasdaq
  • Market Cap
  • WGSWW N/A
  • EIIA N/A
  • IPO Year
  • WGSWW N/A
  • EIIA N/A
  • Fundamental
  • Price
  • WGSWW $0.10
  • EIIA $25.51
  • Analyst Decision
  • WGSWW
  • EIIA
  • Analyst Count
  • WGSWW 0
  • EIIA 0
  • Target Price
  • WGSWW N/A
  • EIIA N/A
  • AVG Volume (30 Days)
  • WGSWW 36.6K
  • EIIA N/A
  • Earning Date
  • WGSWW 02-18-2025
  • EIIA N/A
  • Dividend Yield
  • WGSWW N/A
  • EIIA N/A
  • EPS Growth
  • WGSWW N/A
  • EIIA N/A
  • EPS
  • WGSWW N/A
  • EIIA N/A
  • Revenue
  • WGSWW $305,450,000.00
  • EIIA N/A
  • Revenue This Year
  • WGSWW N/A
  • EIIA N/A
  • Revenue Next Year
  • WGSWW N/A
  • EIIA N/A
  • P/E Ratio
  • WGSWW N/A
  • EIIA N/A
  • Revenue Growth
  • WGSWW 50.79
  • EIIA N/A
  • 52 Week Low
  • WGSWW $0.17
  • EIIA N/A
  • 52 Week High
  • WGSWW $0.21
  • EIIA N/A
  • Technical
  • Relative Strength Index (RSI)
  • WGSWW N/A
  • EIIA 58.88
  • Support Level
  • WGSWW N/A
  • EIIA $25.31
  • Resistance Level
  • WGSWW N/A
  • EIIA $26.33
  • Average True Range (ATR)
  • WGSWW 0.00
  • EIIA 0.15
  • MACD
  • WGSWW 0.00
  • EIIA 0.01
  • Stochastic Oscillator
  • WGSWW 0.00
  • EIIA 30.51

About WGSWW GeneDx Holdings Corp.

GeneDx Holdings Corp delivers personalized and actionable health insights to inform diagnosis, direct treatment and improve drug discovery. The company is uniquely positioned to accelerate the use of genomic and large-scale clinical information to enable precision medicine as the standard of care. The company is at the forefront of transforming healthcare through its various exome and genome testing and interpretation, fueled by one of the world's substantial rare disease data sets.

About EIIA Eagle Point Institutional Income Fund

Eagle Point Institutional Income Fund is a closed-end investment company. Its investment objective is to generate high current income, with a secondary objective to generate capital appreciation.

Share on Social Networks: